Related Experiment Video
Updated: May 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Libman-Sacks endocarditis and embolic cerebrovascular disease
Carlos A Roldan1, Wilmer L Sibbitt, Clifford R Qualls
1Division of Cardiology, University of New Mexico School of Medicine and New Mexico VA Health Care Center, Albuquerque, New Mexico.
Insights
Libman-Sacks endocarditis significantly increases the risk of cerebrovascular disease (CVD) in patients with systemic lupus erythematosus (SLE). This condition is a likely source of cerebral emboli, leading to neurocognitive dysfunction and brain lesions.
Area of Science:
- Cardiology
- Neurology
- Rheumatology
Background:
- The cardioembolic pathogenesis of cerebrovascular disease (CVD) in neuropsychiatric systemic lupus erythematosus (NPSLE) remains incompletely understood.
- Established links between Libman-Sacks endocarditis and CVD in SLE are lacking.
- This study investigates the role of Libman-Sacks endocarditis in SLE-related CVD.
Purpose of the Study:
- To determine if Libman-Sacks endocarditis is a pathogenic factor for cerebrovascular disease (CVD) in systemic lupus erythematosus (SLE).
- To assess the association between Libman-Sacks endocarditis and various manifestations of CVD in SLE patients.
- To evaluate the impact of Libman-Sacks endocarditis on neurocognitive function and brain lesions in SLE.
Main Methods:
- A 6-year prospective study involving 30 patients with acute NPSLE, 46 SLE controls, and 26 healthy controls.
- Comprehensive evaluations included transesophageal echocardiography, Doppler ultrasound, neurocognitive testing, and brain MRI/MRA.
- Clinical follow-up was conducted for a median of 52 months.
Main Results:
- Libman-Sacks vegetations were significantly more prevalent in NPSLE patients (87%) compared to SLE (28%) and healthy controls (8%).
- Patients with vegetations exhibited higher rates of cerebromicroembolism, neurocognitive dysfunction, and cerebral infarcts.
- Libman-Sacks vegetations were identified as independent risk factors for NPSLE, neurocognitive dysfunction, and brain lesions.
Conclusions:
- Libman-Sacks endocarditis is associated with an elevated risk of embolic CVD in SLE patients.
- The findings suggest that Libman-Sacks endocarditis serves as a significant source of cerebral emboli in the context of SLE.
- Therapeutic interventions targeting Libman-Sacks endocarditis may mitigate CVD risk in SLE.
Objectives:
The aim of this study was to determine whether Libman-Sacks endocarditis is a pathogenic factor for cerebrovascular disease (CVD) in systemic lupus erythematosus (SLE).
Background:
A cardioembolic pathogenesis of SLE CVD manifested as: 1) neuropsychiatric systemic lupus erythematosus (NPSLE), including stroke and transient ischemic attacks (TIA); 2) neurocognitive dysfunction; and 3) magnetic resonance imaging of focal brain lesions has not been established.
Methods:
A 6-year study of 30 patients with acute NPSLE (27 women, 38 ± 12 years of age), 46 age- and sex-matched SLE controls without NPSLE (42 women, 36 ± 12 years of age), and 26 age- and sex-matched healthy controls (22 women, 34 ± 11 years of age) who underwent clinical and laboratory evaluations, transesophageal echocardiography, carotid duplex ultrasound, transcranial Doppler ultrasound, neurocognitive testing, and brain magnetic resonance imaging/magnetic resonance angiography. Patients with NPSLE were re-evaluated after 4.5 months of therapy. All patients were followed clinically for a median of 52 months.
Results:
Libman-Sacks vegetations (87%), cerebromicroembolism (27% with 2.5 times more events per hour), neurocognitive dysfunction (60%), and cerebral infarcts (47%) were more common in NPSLE than in SLE (28%, 20%, 33%, and 0%) and healthy controls (8%, 0%, 4%, and 0%, respectively) (all p ≤ 0.009). Patients with vegetations had 3 times more cerebromicroemboli per hour, lower cerebral blood flow, more strokes/TIA and overall NPSLE events, neurocognitive dysfunction, cerebral infarcts, and brain lesion load than those without (all p ≤ 0.01). Libman-Sacks vegetations were independent risk factors of NPSLE (odds ratio [OR]: 13.4; p < 0.001), neurocognitive dysfunction (OR: 8.0; p = 0.01), brain lesions (OR: 5.6; p = 0.004), and all 3 outcomes combined (OR: 7.5; p < 0.001). Follow-up re-evaluations in 18 of 23 (78%) surviving patients with NPSLE demonstrated improvement of vegetations, microembolism, brain perfusion, neurocognitive dysfunction, and lesion load (all p ≤ 0.04). Finally, patients with vegetations had reduced event-free survival time to stroke/TIA, cognitive disability, or death (p = 0.007).
Conclusions:
The presence of Libman-Sacks endocarditis in patients with SLE was associated with a higher risk for embolic CVD. This suggests that Libman-Sacks endocarditis may be a source of cerebral emboli.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Endocarditis IV: Nursing Management